96 related articles for article (PubMed ID: 15890113)
1. [Immunologic characteristics of tumor-derived vascular endothelial cells].
Zhang WJ; Wu LQ; Ye LY; Lou JN
Ai Zheng; 2005 May; 24(5):634-8. PubMed ID: 15890113
[TBL] [Abstract][Full Text] [Related]
2. Adhesion molecules and tumor metastasis: an update.
Tang DG; Honn KV
Invasion Metastasis; 1994-1995; 14(1-6):109-22. PubMed ID: 7657506
[TBL] [Abstract][Full Text] [Related]
3. Role of tumor endothelium in CD4+ CD25+ regulatory T cell infiltration of human pancreatic carcinoma.
Nummer D; Suri-Payer E; Schmitz-Winnenthal H; Bonertz A; Galindo L; Antolovich D; Koch M; Büchler M; Weitz J; Schirrmacher V; Beckhove P
J Natl Cancer Inst; 2007 Aug; 99(15):1188-99. PubMed ID: 17652277
[TBL] [Abstract][Full Text] [Related]
4. CD40-induced countercurrent conduits for tumor escape or elimination?
Murugaiyan G; Martin S; Saha B
Trends Immunol; 2007 Nov; 28(11):467-73. PubMed ID: 17981086
[TBL] [Abstract][Full Text] [Related]
5. 4-O-methylgallic acid down-regulates endothelial adhesion molecule expression by inhibiting NF-kappaB-DNA-binding activity.
Lee G; Na HJ; Namkoong S; Jeong Kwon H; Han S; Ha KS; Kwon YG; Lee H; Kim YM
Eur J Pharmacol; 2006 Dec; 551(1-3):143-51. PubMed ID: 17027748
[TBL] [Abstract][Full Text] [Related]
6. The role of adhesion molecules, alpha v beta 3, alpha v beta 5 and their ligands in the tumor cell and endothelial cell adhesion.
Niu JX; Zhang WJ; Ye LY; Wu LQ; Zhu GJ; Yang ZH; Grau GE; Lou JN
Eur J Cancer Prev; 2007 Dec; 16(6):517-27. PubMed ID: 18090124
[TBL] [Abstract][Full Text] [Related]
7. Interaction of vascular endothelial cells with leukocytes, platelets and cancer cells in inflammation, thrombosis and cancer growth and metastasis.
Geng JG
Acta Pharmacol Sin; 2003 Dec; 24(12):1297-300. PubMed ID: 14653961
[TBL] [Abstract][Full Text] [Related]
8. Review. Leukocyte and endothelial cell adhesion molecules in inflammation focusing on inflammatory heart disease.
Golias C; Tsoutsi E; Matziridis A; Makridis P; Batistatou A; Charalabopoulos K
In Vivo; 2007; 21(5):757-69. PubMed ID: 18019409
[TBL] [Abstract][Full Text] [Related]
9. [The role of adhesion molecules in atherosclerosis and diabetes mellitus].
Gaál Z; Ruzicska E; Valenta B; Somogyi A
Orv Hetil; 2000 Nov; 141(46):2483-6. PubMed ID: 11126680
[TBL] [Abstract][Full Text] [Related]
10. Fibrin and activated platelets cooperatively guide stem cells to a vascular injury and promote differentiation towards an endothelial cell phenotype.
de Boer HC; Verseyden C; Ulfman LH; Zwaginga JJ; Bot I; Biessen EA; Rabelink TJ; van Zonneveld AJ
Arterioscler Thromb Vasc Biol; 2006 Jul; 26(7):1653-9. PubMed ID: 16627804
[TBL] [Abstract][Full Text] [Related]
11. Molecular heterogeneity of tumor endothelium.
Aird WC
Cell Tissue Res; 2009 Jan; 335(1):271-81. PubMed ID: 18726119
[TBL] [Abstract][Full Text] [Related]
12. The in vitro effects of quinupristin/dalfopristin, erythromycin and levofloxacin at low concentrations on the expression of different cell adhesion molecules on the surface of endothelial cells (Eahy926).
Kilic B; Kruse M; Stahlmann R
Toxicology; 2006 Jan; 218(1):30-8. PubMed ID: 16297520
[TBL] [Abstract][Full Text] [Related]
13. Phenotypic and functional differences between human liver cancer endothelial cells and liver sinusoidal endothelial cells.
Wu LQ; Zhang WJ; Niu JX; Ye LY; Yang ZH; Grau GE; Lou JN
J Vasc Res; 2008; 45(1):78-86. PubMed ID: 17901709
[TBL] [Abstract][Full Text] [Related]
14. The proangiogenic phenotype of tumor-derived endothelial cells is reverted by the overexpression of platelet-activating factor acetylhydrolase.
Doublier S; Ceretto M; Lupia E; Bravo S; Bussolati B; Camussi G
Clin Cancer Res; 2007 Oct; 13(19):5710-8. PubMed ID: 17908960
[TBL] [Abstract][Full Text] [Related]
15. Tumor-induced tolerance and immune suppression by myeloid derived suppressor cells.
Marigo I; Dolcetti L; Serafini P; Zanovello P; Bronte V
Immunol Rev; 2008 Apr; 222():162-79. PubMed ID: 18364001
[TBL] [Abstract][Full Text] [Related]
16. GSNO attenuates EAE disease by S-nitrosylation-mediated modulation of endothelial-monocyte interactions.
Prasad R; Giri S; Nath N; Singh I; Singh AK
Glia; 2007 Jan; 55(1):65-77. PubMed ID: 17019693
[TBL] [Abstract][Full Text] [Related]
17. Tumor stromal-derived factor-1 recruits vascular progenitors to mitotic neovasculature, where microenvironment influences their differentiated phenotypes.
Aghi M; Cohen KS; Klein RJ; Scadden DT; Chiocca EA
Cancer Res; 2006 Sep; 66(18):9054-64. PubMed ID: 16982747
[TBL] [Abstract][Full Text] [Related]
18. Cancer cells in transit: the vascular interactions of tumor cells.
Konstantopoulos K; Thomas SN
Annu Rev Biomed Eng; 2009; 11():177-202. PubMed ID: 19413512
[TBL] [Abstract][Full Text] [Related]
19. Presentation of telomerase reverse transcriptase, a self-tumor antigen, is down-regulated by histone deacetylase inhibition.
Pellicciotta I; Cortez-Gonzalez X; Sasik R; Reiter Y; Hardiman G; Langlade-Demoyen P; Zanetti M
Cancer Res; 2008 Oct; 68(19):8085-93. PubMed ID: 18829567
[TBL] [Abstract][Full Text] [Related]
20. Methods to study lymphatic vessel integrins.
Garmy-Susini B; Makale M; Fuster M; Varner JA
Methods Enzymol; 2007; 426():415-38. PubMed ID: 17697894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
